Fast Facts
The average annual trend for specialty pharmaceutical injectables is 17 to 22 percent year over year, largely due to new product development
The average specialty drug treatment cost is approximately
$120 million per one million lives
Specialty injectable pharmaceuticals are used by less than one percent of the patient population, but comprise approximately 20 percent of health plan medical costs
ICORE has dedicated field resources to improve formulary compliance for preferred, cost-efficient therapies
ICORE offers specialty drug distribution services to align with the health plan’s formulary and ultimately generate greater overall savings
